Attenuation of estradiol on the reduction of striatal dopamine by amphetamine in ovariectomized rats

Journal of Cellular Biochemistry

Volumn 108, Issue 6, 2009, Pages 1318-1324

  Yu, Po Ling ^a,b   Wu, Ching I ^b   Lee, Tzong Shyuan ^b   Pan, Wynn H T ^b   Wang, Paulus S ^a,b   Wang, Shyi Wu ^c  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

AMPH; DA; EB; Ovx

Indexed keywords

AMPHETAMINE; DOPAMINE; DOPAMINE TRANSPORTER; ESTRADIOL BENZOATE; TYROSINE 3 MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE ACTION; IMMUNOHISTOCHEMISTRY; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UTERUS WEIGHT; WESTERN BLOTTING;

AMPHETAMINE; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ESTRADIOL; FEMALE; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE 3-MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

ANIMALIA; RATTUS;

EID: 71749087972     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22361     Document Type: Article

References (34)

1. Becker JB. 1999. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 64:803-812.
2. Becker JB, Hu M. 2008. Sex differences in drug abuse. Front Neuroendocrinol 29:36-47.
3. Becker JB, Rudick CN. 1999. Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: A microdialysis study. Pharmacol Biochem Behav 64:53-57.
4. Becker JB, Molenda H, Hummer DL. 2001. Gender differences in the behavioral responses to cocaine and amphetamine. Implications for mechanisms mediating gender differences in drug abuse. Ann NY Acad Sci 937:172-187.
5. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC. 2006. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60:1111-1120. (Pubitemid 44647216)
6. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
7. Butcher RL, Collins WE, Fugo NW. 1974. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology 94:1704-1708.
8. Chang L, Alicata D, Ernst T, Volkow N. 2007. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102:16-32. (Pubitemid 46328220)
9. Flatmark T. 2000. Catecholamine biosynthesis and physiological regulation in neuroendocrine cells. Acta Physiol Scand 168:1-17. (Pubitemid 30128661)
10. Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR. 2007. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681-698. (Pubitemid 46272143)
11. Forgie ML, Stewart J. 1993. Sex difference in amphetamine-induced locomotor activity in adult rats: Role of tetosterone exposure in the neonatal period. Pharmacol Biochem Behav 46:637-645. (Pubitemid 23316550)
12. Fumagalli F, Gainetdinov RR, Wang YM, Valenzano KJ, Miller GW, Caron MG. 1999. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci 19:2424-2431. (Pubitemid 29162392)
13. Hotchkiss AJ, Morgan ME, Gibb JW. 1979. The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxlase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci 25:1373-1378.
14. Justice AJ, De Wit H. 2000. Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav 66:509-515. (Pubitemid 30440843)
15. Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, Javitch JA, Galli A. 2005. Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci 102:3495-3500. (Pubitemid 40328073)
16. Ke JJ, Ho MC, Cherng CG, Tsai YPN, Tsai CW, Yu L. 2008. Ketamine pretreatment exacerbated 3,4-methylenedioxymethamphetamine-induced central dopamine toxicity. Chinese J Physiol 51:65-70.
17. Kosten TR, Kosten TA, McDougle CJ, Hameedi FA, McCance EF, Rosen MI, Oliveto AH, Price LH. 1996. Gender differences in response to intranasal cocaine administration to humans. Biol Psychiatry 39:147-148.
18. Kuczenski R, Segal DS. 1997. An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens. J Neurosci 17:4441-4447. (Pubitemid 27220635)
19. Lin YC, Kuo YM, Liao PC, Cherng CG, Su SW, Yu L. 2007. Attenuation of methamphetamine-induced nigrostriatal dopaminergic neurtoxicity in mice by lipopolysaccharide pretreatment. Chinese J Physiol 50:51-56.
20. Lynch WJ, Roth ME, Carroll ME. 2002. Biological basis of sex differences in drug abuse: Preclinical and clinical studies. Psychopharmacology 164:121-137.
21. Morissette M, Di Paolo T. 1993. Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites. J Neurochem 60:1876-1883. (Pubitemid 23127595)
22. National Bureau of Controlled Drugs, Department of Health, Taiwan. 2008. Department of Health, Taiwan.
23. Patel J, Mooslehner KA, Chan PM, Emson PC, Stamford JA. 2003. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. J Neurochem 85:898-910. (Pubitemid 36578622)
24. Peris J, Decambre N, Coleman-Hardee M, Simpkins J. 1991. Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated [3H]dopamine release. Brain Res 566:255-264.
25. Ricaurte GA, Seiden LS, Schuster CR. 1984. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Res 303:359-364.
26. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ III. 2008. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 70:200-209.
27. Segal DS, Kuczenski R. 1997. An escalating dose "binge" model of amphetamine psychosis: Behavioral and neurochemical characteristics. J Neurosci 17:2551-2566. (Pubitemid 27137421)
28. Sulzer D, Sonders MS, Poulsen NW. 2005. Mechanisms of neurotransmitter release by amphetamines: A review. Prog Neurobiol 75:406-433. (Pubitemid 40834286)
29. Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J. 1980. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181:151-160.
30. Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG. 1997. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19:1285-1296. (Pubitemid 28030547)
31. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ. 1996. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2:699-703. (Pubitemid 26191961)
32. Wu WC, Wang Y, Chai CY. 2008. Acute effects of the cannabinoid receptor agonist WIN55212-2 on dopamine release in rat: An in vivo electrochemical study. Chinese J Physiol 51:152-159.
33. Xiao L, Becker JB. 1994. Quantitative microdialysis determination of extracellular striatal dopamine concentrations in male and female rats: Effects of estrous cycle and gonadectomy. Neurosci Lett 180:155-158. (Pubitemid 24333892)
34. Xu Y, Zhang W, Klaus J, Young J, Koener I, Sheldahl LC, Hum PD, Martinez- Murillo F, Alkayed NJ. 2006. Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection. Proc Natl Acad Sci 103: 14489-14494. (Pubitemid 44484777)